What is the recommended duration of anticoagulant therapy for women with CVT during pregnancy?
For women with CVT during pregnancy, LMWH in full anticoagulant doses should be continued throughout pregnancy, and LMWH or vitamin K antagonist with a target international normalized ratio of 2.0 to 3.0 should be continued for 6 weeks postpartum (for a total minimum duration of therapy of 6 months) (Class I; Level of Evidence C).